Diseases, Conditions, Syndromes

SARS-CoV-2 seroprevalence low in U.S. from July to Sept. 2020

(HealthDay)—Most people in the United States did not have detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies as of September 2020, according to a study published online Nov. 24 in JAMA Internal ...

Medical research

Risk for SARS-CoV-2 infection lower for O, Rh− blood groups

(HealthDay)—Type O and rhesus-negative (Rh−) blood groups seem to be associated with a lower risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online Nov. ...

Diseases, Conditions, Syndromes

Coronavirus treatments: some progress, no panacea

Nearly a year after a mysterious pneumonia emerged in China and began its global spread, there is still no silver bullet treatment for COVID-19 despite an unprecedented effort to discover new medicines or repurpose existing ...

Diseases, Conditions, Syndromes

COVID-19 antibody surveys underestimate infections: study

COVID-19 prevalence surveys that detect levels of antibodies to determine whether people were infected in the past might be unreliable given how quickly these infection-fighting proteins fade, a US government study said Wednesday.

Pediatrics

Predictors of severe disease ID'd in children with SARS-CoV-2

(HealthDay)—Predictors of severe disease have been identified for children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published online Nov. 13 in The Journal of Pediatrics.

page 18 from 40